Background Optimisation of medical therapy is recommended for patients with newly diagnosed non-ischaemic cardiomyopathies (NICM) before consideration of a primary preventive implantable ...
HeartBeam (Nasdaq:BEAT) announced today that it entered into a strategic collaboration with the Icahn School of Medicine at Mount Sinai.
The SmartHeart AI-powered MR workflow. [Image courtesy of Philips] Philips (NYSE: PHG) + announced today that it received FDA 510(k) clearance for its SmartHeart planning solution. SmartHeart, an ...
The global cardiac monitoring and cardiac rhythm management devices market is expected to grow from $27.90b in 2026 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results